Lung Inflammation
22
5
5
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
2 terminated out of 22 trials
83.3%
-3.2% vs benchmark
5%
1 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (22)
PET Imaging CCR2 in Lung Inflammation
Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Cough Capture as a Portal Into the Lung
Treatment of ARDS With Instilled T3
TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air at Rest
Treat COVID-19 Patients With Regadenoson
Bergen Oral Respiratory Intervention Study
The Effects of Different Ventilation Modes on Patients With Pulmonary Lobe Resection
The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled Air
Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers
LUS to Assess Lung Injury After Lung Resection
P-Co-Li (Pulmonary Covid-19 Study)
Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery
LUS to Assess Lung Injury After Lung Lobectomy
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
Assessing NOS Uptake With PET Imaging in Lung Inflammation
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
Commuter Air Pollution Intervention Study